相关实验视频

Updated: Jul 2, 2025

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

OCT4 结质瘤中的表达取决于细胞代谢

Andrey Volnitskiy¹, Konstantin Shabalin¹, Rimma Pantina¹

¹Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roscha 1, 188300 Gatchina, Russia.

Current issues in molecular biology

|February 23, 2024

概括

恶性质瘤中存在OCT4表达,但没有正常的大脑组织,这表明它在瘤发生过程中发挥了作用. 它的表达与代谢重编程有关,特别是α-甲酸水平.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
神经科学是一个神经科学.

背景情况:

转录因子OCT4对于早期胚胎发生和诱导多能干细胞形成至关重要.
OCT4在瘤发生的确切作用,特别是在恶性质瘤中,仍然不清楚.

研究的目的:

为了研究恶性质瘤中的OCT4表达.
探索OCT4在质瘤细胞中的调节机制.

主要方法:

在20个质瘤细胞系和正常成年大脑组织中分析OCT4表达.
在质瘤细胞系中进行OCT4敲击实验.
在不同的条件下培养质瘤细胞 (无血清,无L-氨酸) 并评估OCT4表达.
核磁共振 (NMR) 用于分析克雷布斯周期.

主要成果:

在所有测试的质瘤细胞系中检测到OCT4表达,但在正常的大脑组织中没有.
在一个细胞系中,OCT4的淘汰导致瘤细胞死亡.
无血清和无L-谷氨的条件显著增加了OCT4表达.
数据表明,OCT4调节与α-甲酸 (α-KG) 依存的代谢重编程之间存在联系.

结论:

OCT4是恶性质瘤的潜在标志物.
瘤细胞代谢,特别是α-KG的可用性,可能会调节OCT4的表达.

关键词:

经合组织CT4 质瘤质瘤是一种代谢细胞重新编程的代谢细胞.α-KGG 的使用情况.

更多相关视频

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...